Feed / ALLO

Allogene Therapeutics, Inc.

ALLO

Healthcare · 2.20 +13.4% today

Participation confirmed · construction unavailableMarket checked 20 Aug, 09:30 GMT-4

Jodie situation report

Allogene Therapeutics, Inc.'s move is being confirmed by its market group.

No new filing conclusion is available. 28 of 31 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 9 directly disclosed connections are confirming.

Company+13.4% todayVolume comparison unavailable
Market group28 of 31 activeBiotechnology Therapeutics · active
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 21 of 31 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as NRIX begins moving with the group.

Invalidation: The live read weakens if participation falls to 10 of 31 members or fewer.

Watch this read

Who this business touches

The relationships behind ALLO

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

PFEPfizer, Inc.partnerMay 13, 2026

Research Collaboration and License Agreement with Cellectis In June 2014, Pfizer entered into a Research Collaboration and License Agreement with Cellectis.

CLLSFiling-linked namepartnerMay 13, 2026

Asset Contribution Agreement with Pfizer In April 2018, we entered into an Asset Contribution Agreement (the Pfizer Agreement) with Pfizer pursuant to which we acquired certain assets and assumed certain liabilities from Pfizer, including agreements with Cell…

Depended on by

ARTVArtiva Biotherapeutics, Inc.competitorMay 8, 2026

Our known biopharmaceutical competitors that are developing allogeneic NK, CAR-NK, or CAR-T cell therapies or T-cell engaging bispecific antibodies include, but may not be limited to, the following: Adicet Bio, Inc., Allogene Therapeutics, Inc., Amgen Inc., A…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 9 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ALLO is currently a Participant in the organic co-movement group Biotechnology Therapeutics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.